JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport

Nature Neuroscience

Volumn 9, Issue 7, 2006, Pages 907-916

  Morfini, Gerardo ^a,b   Pigino, Gustavo ^a   Szebenyi, Györgyi ^c   You, Yimei ^a   Pollema, Sarah ^a,b   Brady, Scott T ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MARINE BIOLOGICAL LABORATORY   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; KINESIN; KINESIN 1; POLYGLUTAMINE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCHEMISTRY; CELL LINE; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; DEGENERATIVE DISEASE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; KENNEDY DISEASE; MICROTUBULE; MOTONEURON; NERVE CELL DEGENERATION; NERVE FIBER GROWTH; NERVE FIBER TRANSPORT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SQUID;

ANALYSIS OF VARIANCE; ANIMALS; AXONAL TRANSPORT; BLOTTING, WESTERN; CELL FRACTIONATION; CELL LINE, TUMOR; DECAPODIFORMES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICROTUBULES; NEUROBLASTOMA; PEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33745520772     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1717     Document Type: Article

References (50)

1. Zoghbi, H.Y. & Orr, H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217-247 (2000).
2. Morfini, G., Pigino, G. & Brady, S.T. Polyglutamine expansion diseases: failing to deliver. Trends Mol. Med. 11, 64-70 (2005).
3. Brooks, B.P. & Fischbeck, K.H. Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci. 18, 459-461 (1995).
4. Wilson, C. M. & McPhaul, M.J. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol. Cell Endocrinol. 120, 51-57 (1996).
5. Hirokawa, N. & Takemura, R. Biochemical and molecular characterization of diseases linked to motor proteins. Trends Biochem. Sci. 28, 558-565 (2003).
6. Mandelkow, E. & Mandelkow, E.M. Kinesin motors and disease. Trends Cell Biol. 12, 585-591 (2002).
7. Hafezparast, M. et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300, 808-812 (2003).
8. Reid, E. et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 71, 1189-1194 (2002).
9. Gunawardena, S. et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40, 25-40 (2003).
10. Lee, W.C., Yoshihara, M. & Littleton, J.T. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. USA 101, 3224-3229 (2004).
11. Szebenyi, G. et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40, 41-52 (2003).
12. Feiguin, F., Ferreira, A., Kosik, K.S. & Caceres, A. Kinesin-mediated organelle translocation revealed by specific cellular manipulations. J. Cell Biol. 127, 1021-1039 (1994).
13. Morfini, G., Szebenyi, G., Elluru, R., Ratner, N. & Brady, S.T. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 23, 281-293 (2002).
14. Morfini, G., Szebenyi, G., Richards, B. & Brady, S.T. Regulation of kinesin: implications for neuronal development. Dev. Neurosci. 23, 364-376 (2001).
15. Morfini, G., Pigino, G., Beffert, U., Busciglio, J. & Brady, S.T. Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med. 2, 89-99 (2002).
16. Pigino, G., Morfini, G., Mattson, M.P., Brady, S.T. & Busciglio, J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23, 4499-4508 (2003).
17. Chevalier-Larsen, E.S. et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 24, 4778-4786 (2004).
18. Cowan, K.J., Diamond, M.I. & Welch, W.J. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum. Mol. Genet. 12, 1377-1391 (2003).
19. LaFevre-Bernt, M.A. & Ellerby, L.M. Kennedy's disease. Phosphorylation of the polyglutamine-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death. J. Biol. Chem. 278, 34918-34924 (2003).
20. Brady, S.T., Pfister, K.K. & Bloom, G.S. A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. Proc. Natl. Acad. Sci. USA 87, 1061-1065 (1990).
21. Avila, D.M., Allman, D.R., Gallo, J.M. & McPhaul, M.J. Androgen receptors containing expanded polyglutamine tracts exhibit progressive toxicity when stably expressed in the neuroblastoma cell line, SH-SY 5Y. Exp. Biol. Med. (Maywood) 228, 982-990 (2003).
22. 2+-dependent dephosphorylation of kinesin heavy chain on β-granules in pancreatic β-cells. Implications for regulated β-granule transport and insulin exocytosis. J. Biol. Chem. 277, 24232-24242 (2002).
23. Hollenbeck, P.J. Phosphorylation of neuronal kinesin heavy and light chains in vivo. J. Neurochem. 60, 2265-2275 (1993).
24. Grant, P. & Pant, H.C. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 29, 843-872 (2000).
25. Morfini, G. et al. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23, 2235-2245 (2004).
26. Fabian, M.A. et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat. Biotechnol. 23, 329-336 (2005).
27. Coffey, E.T. et al. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J. Neurosci. 22, 4335-4345 (2002).
28. Coffey, E.T., Hongisto, V., Dickens, M., Davis, R.J. & Courtney, M.J. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J. Neurosci. 20, 7602-7613 (2000).
29. Bennett, B. L. et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98, 13681-13686 (2001).
30. Barr, R.K., Kendrick, T.S. & Bogoyevitch, M.A. Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277, 10987-10997 (2002).
31. Ross, C.A. & Poirier, M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 10 suppl. Suppl,: S10-S17 (2004).
32. Sopher, B.L. et al. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 41, 687-699 (2004).
33. Johnson, G.L. & Lapadat, R. Mitogenactivated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912 (2002).
34. Jorgensen, J.S. & Nilson, J.H. AR suppresses transcription of the á glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. Mol. Endocrinol. 15, 1496-1504 (2001).
35. Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843-854 (2002).
36. Ishihara, H., Kanda, F., Nishio, H., Sumino, K. & Chihara, K. Clinical features and skewed X-chromosome inactivation in female carriers of X-linked recessive spinal and bulbar muscular atrophy. J. Neurol. 248, 856-860 (2001).
37. Schmidt, B.J., Greenberg, C.R., Allingham-Hawkins, D.J. & Spriggs, E.L. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59, 770-772 (2002).
38. Burnstein, K.L. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy. J. Cell. Biochem. 95, 657-669 (2005).
39. McManamny, P. et al. A mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 11, 2103-2111 (2002).
40. Abel, A., Walcott, J., Woods, J., Duda, J. & Merry, D.E. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum. Mol. Genet. 10, 107-116 (2001).
41. McQuarrie, I.G., Brady, S.T. & Lasek, R.J. Retardation in axonal transport of cytoskeletal elements during maturation and aging. Neurobiol. Aging 10, 359-365 (1989).
42. Traish, A.M., Muller, R.E. & Wotiz, H.H. Binding of 7 α, 17 α-dimethyl-19-nortestosterone (mibolerone) to androgen and progesterone receptors in human and animal tissues. Endocrinology 118, 1327-1333 (1986).
43. Liu, J. & Lin, A. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 15, 36-42 (2005).
44. Piccioni, F. et al. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. FASEB J. 16, 1418-1420 (2002).
45. Goemaere-Vanneste, J., Courad, J.Y., Hassig, R., Di Giamberardino, L. & van den Bosch de Aguilar, P. Reduced axonal transport of the G4 molecular form of acetylcholinesterase in the rat sciatic nerve during aging. J. Neurochem. 51, 1746-1754 (1988).
46. Gatchel, J.R. & Zoghbi, H.Y. Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6, 743-755 (2005).
47. Gioeli, D. et al. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol. Endocrinol. 20, 503-515 (2006).
48. Cao, J. et al. Distinct requirements for p38á and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J. Biol. Chem. 279, 35903-35913 (2004).
49. Morfini, G., Tsai, M., Szebenyi, G. & Brady, S.T. Approaches to study interactions between kinesin motors and membrains. in Kinesin Protocols (ed. Vernos, I.) 147-162 (Humana Press, Totowa, New Jersey, 2000).
50. Kuiper, G.G., de Ruiter, P.E., Trapman, J., Jenster, G. & Brinkmann, A.O. In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein. Biochem. J. 296, 161-167 (1993).